IBM's Watson: Can it improve returns on R&D?
IBM on Thursday will outline a new advance in its Watson cognitive computing system that could ultimately help the returns on research and development. At an event in New York, IBM will show off new uses for Watson as it aims to commercialize cognitive computing and make its Watson Group a growth driver. IBM launched its Watson Group in January and invested $1 billion into the effort. To date, IBM has been deploying Watson in key verticals such as healthcare and life sciences and delivering its Watson Discovery Advisor as a cloud service. The catch is that Watson has to be prepped properly before deployed as a service. The system has to train itself as it ingests content that an IBM client wants.
- Providers' Push to Consolidate Roils Payers
- Former NQF Co-Chair Linked to Conflicts of Interest in Journal Probe
- As Retail Clinics Surge, Quality Metrics MIA
- RN Named Chief Patient Experience Officer
- Medicare Cost, Quality Data Tools Weak, Says GAO
- No Employee Satisfaction, No Patient-Centered Culture
- Six Not-So-Good Reasons for Avoiding Population Health
- In PCMH, the 'P' is Not for 'Physician'
- Population Health Pays Off for NY Collaborative
- How Simple Data Analytics is Driving Physician Incentives